{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:39:41Z","timestamp":1794461981709,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T00:00:00Z","timestamp":1324339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s11102-011-0369-1","type":"journal-article","created":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T06:52:46Z","timestamp":1324277566000},"page":"562-570","source":"Crossref","is-referenced-by-count":38,"title":["Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly na\u00efve to medical therapy and radiation: what to follow, GH or IGF-1 values?"],"prefix":"10.1007","volume":"15","author":[{"given":"Jessica A.","family":"Brzana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris G.","family":"Yedinak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny B.","family":"Delashaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hume S.","family":"Gultelkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,20]]},"reference":[{"issue":"1","key":"369_CR1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1009965803750","volume":"2","author":"IM Holdaway","year":"1999","unstructured":"Holdaway IM, Rajasoorya C (1999) Epidemiology of acromegaly. Pituitary 2(1):29\u201341","journal-title":"Pituitary"},{"issue":"3","key":"369_CR2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","volume":"72","author":"A Fernandez","year":"2010","unstructured":"Fernandez A, Karavitaki N, Wass JA (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72(3):377\u2013382","journal-title":"Clin Endocrinol (Oxf)"},{"key":"369_CR3","doi-asserted-by":"crossref","unstructured":"Rosario PW, Calsolari MR (2011) Screening for acromegaly by application of a simple questionnaire evaluating the enlargement of extremities in adult patients seen at primary health care units. Pituitary. doi: 10.1007\/s11102-011-0302-7","DOI":"10.1007\/s11102-011-0302-7"},{"issue":"3","key":"369_CR4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2265.2008.03221.x","volume":"69","author":"HJ Schneider","year":"2008","unstructured":"Schneider HJ, Sievers C, Saller B, Wittchen HU, Stalla GK (2008) High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clin Endocrinol (Oxf) 69(3):432\u2013435","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"369_CR5","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","volume":"91","author":"AF Daly","year":"2006","unstructured":"Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91(12):4769\u20134775","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"369_CR6","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"A Giustina","year":"2010","unstructured":"Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141\u20133148","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"369_CR7","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355(24):2558\u20132573","journal-title":"N Engl J Med"},{"issue":"11","key":"369_CR8","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1172\/JCI39375","volume":"119","author":"S Melmed","year":"2009","unstructured":"Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119(11):3189\u20133202","journal-title":"J Clin Invest"},{"issue":"3","key":"369_CR9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11102-011-0308-1","volume":"14","author":"ME Sughrue","year":"2011","unstructured":"Sughrue ME, Chang EF, Gabriel RA, Aghi MK, Blevins LS (2011) Excess mortality for patients with residual disease following resection of pituitary adenomas. Pituitary 14(3):276\u2013283","journal-title":"Pituitary"},{"issue":"2","key":"369_CR10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","volume":"89","author":"IM Holdaway","year":"2004","unstructured":"Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89(2):667\u2013674","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"369_CR11","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1210\/jc.2009-1097","volume":"94","author":"M Sherlock","year":"2009","unstructured":"Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, Hawkins MM, Bates AS, Stewart PM (2009) ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab 94(11):4216\u20134223","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"369_CR12","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.3171\/2010.7.FOCUS10154","volume":"29","author":"M Fleseriu","year":"2010","unstructured":"Fleseriu M, Delashaw JB Jr, Cook DM (2010) Acromegaly: a review of current medical therapy and new drugs on the horizon. Neurosurg Focus 29(4):E15","journal-title":"Neurosurg Focus"},{"issue":"3","key":"369_CR13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4158\/EP.10.3.213","volume":"10","author":"DM Cook","year":"2004","unstructured":"Cook DM, Ezzat S, Katznelson L, Kleinberg DL, Laws ER Jr, Nippoldt TB, Swearingen B, Vance ML (2004) AACE medical guidelines for clinical practice for the diagnosis and treatment of acromegaly. Endocr Pract 10(3):213\u2013225","journal-title":"Endocr Pract"},{"issue":"4","key":"369_CR14","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1210\/jc.2007-2104","volume":"93","author":"O Alexopoulou","year":"2008","unstructured":"Alexopoulou O, Bex M, Abs R, T\u2019Sjoen G, Velkeniers B, Maiter D (2008) Divergence between growth hormone and insulin-like growth factor-I concentrations in the follow-up of acromegaly. J Clin Endocrinol Metab 93(4):1324\u20131330","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"369_CR15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1055\/s-0029-1239522","volume":"42","author":"PC Elias","year":"2010","unstructured":"Elias PC, Lugao HB, Pereira MC, Machado HR, Castro M, Moreira AC (2010) Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity. Horm Metab Res 42(1):50\u201355","journal-title":"Horm Metab Res"},{"issue":"5","key":"369_CR16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ghir.2008.02.001","volume":"18","author":"EO Machado","year":"2008","unstructured":"Machado EO, Taboada GF, Neto LV, van Haute FR, Correa LL, Balarini GA, Shrank Y, Goulart M, Gadelha MR (2008) Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR. Growth Horm IGF Res 18(5):389\u2013393","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"369_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3171\/jns.1998.89.3.0353","volume":"89","author":"PU Freda","year":"1998","unstructured":"Freda PU, Wardlaw SL, Post KD (1998) Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. J Neurosurg 89(3):353\u2013358","journal-title":"J Neurosurg"},{"issue":"9","key":"369_CR18","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1210\/jc.2011-0554","volume":"96","author":"JA Jane Jr","year":"2011","unstructured":"Jane JA Jr, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, Marshall JC, Laws ER Jr, Vance ML (2011) Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab 96(9):2732\u20132740","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"369_CR19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ghir.2010.09.003","volume":"20","author":"TE Wu","year":"2010","unstructured":"Wu TE, Lin HD, Lu RA, Wang ML, Chen RL, Chen HS (2010) The role of insulin-like growth factor-1 and growth hormone in the mortality of patients with acromegaly after trans-sphenoidal surgery. Growth Horm IGF Res 20(6):411\u2013415","journal-title":"Growth Horm IGF Res"},{"issue":"7","key":"369_CR20","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1210\/jc.2004-1381","volume":"90","author":"R Kauppinen-M\u00e4kelin","year":"2005","unstructured":"Kauppinen-M\u00e4kelin R, Sane T, Reunanen A, V\u00e4lim\u00e4ki MJ, Niskanen L, Markkanen H, L\u00f6yttyniemi E, Ebeling T, Jaatinen P, Laine H, Nuutila P, Salmela P, Salmi J, Stenman U-H, Viikari J, Voutilainen E (2005) A nationwide survey of mortality in acromegaly. J Clin Endocrinol Metab 90(7):4081\u20134086","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"369_CR21","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2265.2009.03578.x","volume":"71","author":"N Karavitaki","year":"2009","unstructured":"Karavitaki N, Fernandez A, Fazal-Sanderson V, Wass JA (2009) The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly. Clin Endocrinol (Oxf) 71(6):840\u2013845","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"369_CR22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2265.2008.03461.x","volume":"71","author":"M Sherlock","year":"2009","unstructured":"Sherlock M, Aragon Alonso A, Reulen RC, Ayuk J, Clayton RN, Holder G, Sheppard MC, Bates A, Stewart PM (2009) Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly. Clin Endocrinol (Oxf) 71(1):74\u201381","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5\u20136","key":"369_CR23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cca.2010.11.008","volume":"412","author":"DR Clemmons","year":"2011","unstructured":"Clemmons DR (2011) Clinical laboratory indices in the treatment of acromegaly. Clin Chim Acta; Int J Clin Chem 412(5\u20136):403\u2013409","journal-title":"Clin Chim Acta; Int J Clin Chem"},{"issue":"2","key":"369_CR24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1210\/jc.2008-1371","volume":"94","author":"JD Carmichael","year":"2009","unstructured":"Carmichael JD, Bonert VS, Mirocha JM, Melmed S (2009) The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. J Clin Endocrinol Metab 94(2):523\u2013527","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"369_CR25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/EJE-09-0053","volume":"161","author":"P Kamenicky","year":"2009","unstructured":"Kamenicky P, Dos Santos C, Espinosa C, Salenave S, Galland F, Le Bouc Y, Maison P, Bougn\u00e8res P, Chanson P (2009) D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly. Euro J Endocrinol 161(2):231\u2013235","journal-title":"Euro J Endocrinol"},{"issue":"2","key":"369_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/meta.2003.50036","volume":"52","author":"H Vierhapper","year":"2003","unstructured":"Vierhapper H, Heinze G, Gessl A, Exner M, Bieglmayr C (2003) Use of the oral glucose tolerance test to define remission in acromegaly. Metabolism 52(2):181\u2013185","journal-title":"Metabolism"},{"key":"369_CR27","doi-asserted-by":"crossref","unstructured":"Boero L, Manavela M, Danilowicz K, Alfieri A, Ballarino MC, Chervin A, Garcia-Basavilbaso N, Glerean M, Guitelman M, Loto MG, Nahmias JA, Rogozinski AS, Servidio M, Vitale NM, Katz D, Fainstein Day P, Stalldecker G, Mallea-Gil MS (2011) Comparison of two immunoassays in the determination of IGF-I levels and its correlation with oral glucose tolerance test (OGTT) and with clinical symptoms in acromegalic patients. Pituitary. doi: 10.1007\/s11102-011-0351-y","DOI":"10.1007\/s11102-011-0351-y"},{"issue":"5","key":"369_CR28","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1210\/jc.2009-2634","volume":"95","author":"AT Faje","year":"2010","unstructured":"Faje AT, Barkan AL (2010) Basal, but not pulsatile, growth hormone secretion determines the ambient circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab 95(5):2486\u20132491","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"369_CR29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2265.2009.03556.x","volume":"71","author":"PU Freda","year":"2009","unstructured":"Freda PU (2009) Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clin Endocrinol (Oxf) 71(2):166\u2013170","journal-title":"Clin Endocrinol (Oxf)"},{"key":"369_CR30","doi-asserted-by":"crossref","unstructured":"Minuto FM, Resmini E, Boschetti M, Rebora A, Fazzuoli L, Arvigo M, Giusti M, Ferone D (2011) Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. Pituitary. doi: 10.1007\/s11102-011-0313-4","DOI":"10.1007\/s11102-011-0313-4"},{"issue":"5","key":"369_CR31","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1210\/jc.2003-032150","volume":"89","author":"D Milani","year":"2004","unstructured":"Milani D, Carmichael JD, Welkowitz J, Ferris S, Reitz RE, Danoff A, Kleinberg DL (2004) Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development. J Clin Endocrinol Metab 89(5):2271\u20132274","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"369_CR32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1373\/clinchem.2010.150631","volume":"57","author":"DR Clemmons","year":"2011","unstructured":"Clemmons DR (2011) Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem 57(4):555\u2013559","journal-title":"Clin Chem"},{"issue":"4","key":"369_CR33","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/jc.2007-2084","volume":"93","author":"AM Arafat","year":"2008","unstructured":"Arafat AM, Mohlig M, Weickert MO, Perschel FH, Purschwitz J, Spranger J, Strasburger CJ, Schofl C, Pfeiffer AF (2008) Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J Clin Endocrinol Metab 93(4):1254\u20131262","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-011-0369-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-011-0369-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-011-0369-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:08:13Z","timestamp":1559354893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-011-0369-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,20]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["369"],"URL":"https:\/\/doi.org\/10.1007\/s11102-011-0369-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717951850.793457150","asserted-by":"object"}]},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,20]]}}}